Literature DB >> 29373673

A 17-Year-Old Boy With Right Face Palsy, Left Leg Weakness, and Lytic Skull-Bone Lesions.

Ibukunoluwa C Akinboyo1, Genevieve M Crane2, Lingling Chen1, Ravit Arav-Boger1.   

Abstract

Human T-cell lymphotropic virus (HTLV), an infection that is endemic in certain parts of Asia, Africa, and South America, has been associated with malignancy and neurological deficits. Here, we describe a pediatric patient with chronic HTLV-I infection who developed complications associated with HTLV-I (ie, adult T-cell leukemia/lymphoma and HTLV-I-associated myelopathy/tropical spastic paraparesis). To our knowledge, this presentation in a child has never been described. The patient underwent a bone marrow transplant and, at the time of this writing, was in remission. This case report highlights the fact that HTLV-related complications, previously expected to occur after decades of infection, also can occur in pediatric patients, particularly those who acquired HTLV-I perinatally.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29373673      PMCID: PMC6276027          DOI: 10.1093/jpids/pix101

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  19 in total

1.  Breast feeding and the risks of viral transmission.

Authors:  C A Michie; J Gilmour
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

3.  Update: serologic testing for human T-lymphotropic virus type I--United States, 1989 and 1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1992-04-17       Impact factor: 17.586

4.  Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Authors:  Yun Brenda Chang; Zhanna Kaidarova; Daniel Hindes; Marjorie Bravo; Nancy Kiely; Hany Kamel; Denise Dubay; Barbara Hoose; Edward L Murphy
Journal:  J Infect Dis       Date:  2013-09-24       Impact factor: 5.226

Review 5.  Primary prevention of HTLV-I in Japan.

Authors:  S Hino; S Katamine; H Miyata; Y Tsuji; T Yamabe; T Miyamoto
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

6.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

7.  Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission.

Authors:  María C Frutos; Rene Gastaldello; Marcos Balangero; Carlos Remondegui; Sebastián Blanco; Koko Otsuki; Ana Carolina Paulo Vicente; David Elías; Arnaldo Mangeaud; Silvia Nates; Sandra Gallego
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

8.  Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.

Authors:  Martin Montes; Cesar Sanchez; Kristien Verdonck; Jordan E Lake; Elsa Gonzalez; Giovanni Lopez; Angelica Terashima; Thomas Nolan; Dorothy E Lewis; Eduardo Gotuzzo; A Clinton White
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09

Review 9.  Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma.

Authors:  Jean A Yared; Amy S Kimball
Journal:  Cancers (Basel)       Date:  2015-11-25       Impact factor: 6.639

Review 10.  Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission.

Authors:  Florent Percher; Patricia Jeannin; Sandra Martin-Latil; Antoine Gessain; Philippe V Afonso; Aurore Vidy-Roche; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.